Barbara M Fischer

Summary

Publications

  1. ncbi Preoperative staging of lung cancer with combined PET-CT
    Barbara Fischer
    Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
    N Engl J Med 361:32-9. 2009
  2. ncbi Multimodality approach to mediastinal staging in non-small cell lung cancer. Faults and benefits of PET-CT: a randomised trial
    Barbara M Fischer
    Department of Clinical Physiology, Nuclear Medicine and PET, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
    Thorax 66:294-300. 2011
  3. ncbi PET-CT in Preoperative Staging of Lung Cancer
    Barbara M Fischer
    Rigshospitalet, Copenhagen, Denmark
    N Engl J Med 364:980-1. 2011
  4. ncbi PET/CT imaging in response evaluation of patients with small cell lung cancer
    Barbara M Fischer
    Department of Nuclear Medicine and PET, Centre of Diagnostic Imaging, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
    Lung Cancer 54:41-9. 2006
  5. ncbi The future in diagnosis and staging of lung cancer: positron emission tomography
    Barbara M Fischer
    Department of Nuclear Medicine and PET, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
    Respiration 73:267-76. 2006
  6. ncbi How few cancer cells can be detected by positron emission tomography? A frequent question addressed by an in vitro study
    Barbara M Fischer
    Department of Clinical Physiology, Nuclear Medicine and PET, Copenhagen University Hospital, Copenhagen, Denmark
    Eur J Nucl Med Mol Imaging 33:697-702. 2006

Detail Information

Publications6

  1. ncbi Preoperative staging of lung cancer with combined PET-CT
    Barbara Fischer
    Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
    N Engl J Med 361:32-9. 2009
    ..The purpose of this randomized study was to evaluate the clinical effect of combined positron-emission tomography and computed tomography (PET-CT) on preoperative staging of NSCLC...
  2. ncbi Multimodality approach to mediastinal staging in non-small cell lung cancer. Faults and benefits of PET-CT: a randomised trial
    Barbara M Fischer
    Department of Clinical Physiology, Nuclear Medicine and PET, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
    Thorax 66:294-300. 2011
    ..The objective of this study was to describe faults and benefits of positron emission tomography (PET)-CT in multimodality mediastinal staging...
  3. ncbi PET-CT in Preoperative Staging of Lung Cancer
    Barbara M Fischer
    Rigshospitalet, Copenhagen, Denmark
    N Engl J Med 364:980-1. 2011
    ..The primary end point of our study was the number of futile thoracotomies that had been performed, as determined by the intention-to-treat analysis. Thus, the error does not change the published outcome. We . . ...
  4. ncbi PET/CT imaging in response evaluation of patients with small cell lung cancer
    Barbara M Fischer
    Department of Nuclear Medicine and PET, Centre of Diagnostic Imaging, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
    Lung Cancer 54:41-9. 2006
    ..However, data on SCLC is scarce and mainly retrospective. This prospective study assesses the use of PET (positron emission tomography) and PET/CT in response evaluation of patients with small cell lung cancer (SCLC)...
  5. ncbi The future in diagnosis and staging of lung cancer: positron emission tomography
    Barbara M Fischer
    Department of Nuclear Medicine and PET, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
    Respiration 73:267-76. 2006
    ....
  6. ncbi How few cancer cells can be detected by positron emission tomography? A frequent question addressed by an in vitro study
    Barbara M Fischer
    Department of Clinical Physiology, Nuclear Medicine and PET, Copenhagen University Hospital, Copenhagen, Denmark
    Eur J Nucl Med Mol Imaging 33:697-702. 2006
    ..Positron emission tomography (PET) has gained widespread use in cancer diagnosis and treatment, but how many malignant cells are required for a tumour to be detected by PET?..